Registration AFACTT ECI Satellite Symposium Amsterdam

Share itShare on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Print this pageEmail this to someone



AFACTT ECI Satellite Symposium – Amsterdam – 2 September 2018, 10.00- 14.30 – RAI Amsterdam

No additional fee but registration required – Limited places – Closing date registration: 19 August  2018


Advancements in Tolerance-inducing cellular therapies – an update by AFACTT


The AFACTT consortium, – EU COST Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies – is proud to announce that it will organize its own AFACTT ECI satellite symposium in the framework of the European Congress of Immunology (ECI), which will take place in Amsterdam (2-5 September 2018).

The symposium is a great opportunity for attendants to gain knowledge on the progress in the field of Tolerance Inducing Cellular Therapies (e.g. tolerogenic dendritic cells and Tregs). Starting with inspiring talks of AFACTT consortium members the symposium seeks also to interactively exchange and discuss insights and views with attendants.

In this framework, AFACTT opens a CALL FOR ABSTRACTS. From the submitted abstracts two authors will be selected and are invited to give a short talk. To participate in the Call, please fill out the Title of the abstract in the registration form. You will then receive further details on the Call and how to proceed. UPDATE: CALL FOR ABSTRACTS closed

The AFACTT satellite meeting is open to everyone, without additional fees, but registration is required. Due to limited places, admission is based on first registration.

Update 20 August 2018: REGISTRATION CLOSED



(Subject to updates; without previous warnings)

ECI Satellite symposium –  Advancements in Tolerance-inducing cellular therapies – an update by AFACTT (EU COST action to focus and accelerate cellular tolerance-inducing therapies)

Sunday, September 2, 10:00-14:30

RAI Amsterdam, Room: G 102-103

10:00  Welcome

Anja ten Brinke (Sanquin, Amsterdam, the Netherlands) ;

Eva M Martinez Cáceres (Germans Trias I Pujol Hospital, Universitat Autonoma de Barcelona, Spain)

10: 15

The ONE Study – clinical trials testing immune cell therapy in kidney transplant recipients
Edward K. Geissler (University Hospital Regensburg, Germany)


Stability of Regulatory T cells for tolerance inducing immunotherapy
Irma Joosten (Radboud University Medical Center, Nijmegen, the Netherlands)


Tolerogenic mesenchymal stem cells in corneal transplantation- from bench to bedside
Thomas Ritter (National University of Ireland, Galway, Ireland)


Selected abstract:

Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases
Manon Jansen (Utrecht University, the Netherlands)

12:00 Lunch Break


Selected abstract:

Modulation of the CD27/CD70 co-stimulatory pathway in human regulatory T cells for enhanced immunotherapy
Rebeca Arroyo (Oxford University, United Kingdom)


Interactive workshop: Minimal information Models on cell-based tolerogenic therapies: ‘MITAP/MITREG and beyond’
Phillip Lord (Newcastle University, UK) and Piotr Trzonkowski (Medical University of Gdansk, Poland)